National Institutes of Health: Arthritis, Juvenile trials

The registry lists 10 Arthritis, Juvenile studies with National Institutes of Health as lead sponsor. 2 are open to participants now and 3 have results posted.

Phase 1 1Phase 2 5Phase 3 1No phase 3(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Hemophagocytic Lymphohistiocytosis (HLH) Evaluation and Research of Clinical, ImmUnoLogic and TranscriptomE StudyRecruitingNCT06339177
• Natural History and Development of SpondyloarthritisRecruitingNCT01422694
• Transcutaneous Cervical Vagus Nerve Stimulation (tcVNS) in JIATerminatedNCT05710640Phase 2Results posted
• COVID-19 Booster Vaccine in Autoimmune Disease Non-RespondersTerminatedNCT05000216Phase 2Results posted
• Human Anti-Tac (Daclizumab) to Treat Juvenile Idiopathic Arthritis (JIA)-Associated UveitisCompletedNCT00130637Phase 2Results posted
• Juvenile Rheumatoid Arthritis Research RegistryCompletedNCT00090571
• Infliximab to Treat Children With Juvenile Rheumatoid ArthritisTerminatedNCT00029042Phase 2
• The Safety and Efficacy of a Tumor Necrosis Factor Receptor Fusion Protein on Uveitis Associated With Juvenile Rheumatoid ArthritisStatus unknownNCT00012506Phase 3
• TNRF:Fc to Treat Eye Inflammation in Juvenile Rheumatoid ArthritisCompletedNCT00001862Phase 2
• The Safety and Efficacy of Chicken Type II Collagen on Uveitis Associated With Juvenile Rheumatoid ArthritisCompletedNCT00001614Phase 1